WASHINGTON, D.C. (December 27, 2002) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement on reports that the first human being had been cloned:
“BIO reiterates its strong opposition to human cloning on both safety and ethical grounds. If this announcement is proven true, we hope the child enjoys a full, healthy life and has a loving family.”
The Biotechnology Industry Organization (BIO) represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products. For more information on BIO, visit our website at www.bio.org.